Clinical Utility of β₃-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations

Jan Krhut1 Department of Urology, University Hospital, Ostrava, Czech Republic;2 Department of Surgical Studies, Medical Faculty, Ostrava University, Ostrava, Czech RepublicCorrespondence[email protected]

https://orcid.org/0000-0003-4205-5926

Barbora Skugarevská1 Department of Urology, University Hospital, Ostrava, Czech Republic;2 Department of Surgical Studies, Medical Faculty, Ostrava University, Ostrava, Czech Republic

David Míka1 Department of Urology, University Hospital, Ostrava, Czech Republic;2 Department of Surgical Studies, Medical Faculty, Ostrava University, Ostrava, Czech Republic

Lars Lund3 Research Unit of Urology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark;4 Department of Urology, Odense University Hospital, Odense, Denmark

https://orcid.org/0000-0003-0391-9568

Peter Zvara3 Research Unit of Urology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark;4 Department of Urology, Odense University Hospital, Odense, Denmark;5 Biomedical Laboratory, University of Southern Denmark, Odense, Denmark

Clinical Utility of β₃-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Clinical Utility of β₃-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations